Apellis Pharmaceuticals, Inc. (APLS)
$41.03+0.00%Close
BUYBULL · day 33
Key stats
- Market cap
- $5.3B
- Beta
- -0.25
- P/E (TTM)
- 38.71
- 1W
- +0.00%
- 1M
- +0.39%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -2.60%
Industry peers
FMP comparable companies · ranked by market cap
- KNSABUYKiniksa Pharmaceuticals International, plc$5.8BBULLQ 24$76.31+1.31%
- CDTXCidara Therapeutics, Inc.$5.6B$221.38
- SRRKSELLScholar Rock Holding Corporation$5.2BCRISISQ 22$43.40-0.02%
- ADPTBUYAdaptive Biotechnologies Corporation$4.8BCRISISQ 6$29.84+1.53%
- CPRXBUYCatalyst Pharmaceuticals, Inc.$3.9BBULLQ 20$31.49+0.00%
- IDYASELLIDEAYA Biosciences, Inc.$3.6BBEARQ 25$38.06+0.14%
- BEAMBUYBeam Therapeutics Inc.$2.6BRECOVERYQ 14$25.67+4.47%
- RXRXBUYRecursion Pharmaceuticals, Inc.$2.5BRECOVERYQ 1$4.78+10.38%
- MLYSSELLMineralys Therapeutics, Inc.$2.1BCRISISQ 19$23.30+4.42%
- AGIOSELLAgios Pharmaceuticals, Inc.$1.9BRECOVERYQ 4$31.25-0.34%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
Loading headlines…